ZAI LAB LIMITED Inventory, Finished Goods, Gross
ZAI LAB LIMITED (ZLAB) had Inventory, Finished Goods, Gross of $8.70 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2022-11-09
- 2022-09-30: Inventory, Finished Goods, Gross $8.70M.
- 2022-06-30: Inventory, Finished Goods, Gross $4.34M.
- 2022-03-31: Inventory, Finished Goods, Gross $4.73M.
- 2021-12-31: Inventory, Finished Goods, Gross $5.63M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2022-09-30 | $8.70M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.34M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.73M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $5.63M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $5.30M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.48M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $2.70M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.04M 10-K · filed 2022-03-01 |
| 2020-06-30 | $838.00K 6-K · filed 2020-09-11 |
| 2019-12-31 | $593.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |